Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects

Trial Identifier: 20090519
Sponsor: AstraZeneca
NCTID:: NCT01258205
Start Date: February 2011
Primary Completion Date: February 2015

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Australia, QLD Herston, QLD, Australia, 4029
Australia, SA Adelaide, SA, Australia, 5000
Australia, VIC Prahran, VIC, Australia, 3181
United States, NJ Berlin, NJ, United States, 08009
United States, NY Stony Brook, NY, United States, 11794
United States, OK Oklahoma City, OK, United States, 73102
United States, VA Richmond, VA, United States, 23291